NSB 0.00% 3.9¢ neuroscientific biopharmaceuticals ltd

Ann: Investor Update Presentation, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 125 Posts.
    lightbulb Created with Sketch. 228
    that was the study which kicked off Emtin b being licensed, has been public knowledge since day 1. It's a shame that Matt was allowed to run this thing into the ground, no Ph2 mid 2025? - that hurts. especially since all signs for safety point to all good... all the best to holders; this new CEO seems like he could be good...
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.